- Tytuł:
- A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma
- Autorzy:
-
Gamberi, Barbara
Zitt, Christof
Suter, Cosima
Fey, Martin F.
Leupin, Nicolas
Jurczyszyn, Artur
Grząśko, Norbert
Iversen, Katrine F.
Trautmann‐Grill, Karolin
Szarejko, Monika
Stavropoulou, Vaia
Pour, Ludek
Vacca, Angelo
Legenne, Philippe
Bringhen, Sara
Dawson, Keith M.
Khandanpour, Cyrus
Goldschmidt, Hartmut
Stumpp, Michael T.
Knop, Stefan - Dostawca treści:
- Repozytorium Uniwersytetu Jagiellońskiego
Artykuł